Cargando…

The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK

PURPOSE: Comparing gonadotrophin-releasing hormone (GnRH) antagonists and agonists as androgen deprivation therapy for advanced prostate cancer (PC). METHODS: This article stems from a round-table meeting in December 2014 to compare the properties of GnRH agonists and antagonists in the published li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosario, Derek J., Davey, Patrick, Green, James, Greene, Damien, Turner, Bruce, Payne, Heather, Kirby, Mike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114327/ https://www.ncbi.nlm.nih.gov/pubmed/27097892 http://dx.doi.org/10.1007/s00345-016-1818-2

Ejemplares similares

Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)

Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
por: Xia, Min, et al.
Publicado: (2021)

Relugolix: A new kid on the block among gonadotrophin-releasing hormone antagonists
por: Fragkoulis, Charalampos, et al.
Publicado: (2021)

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors.
por: Qayum, A., et al.
Publicado: (1990)

Optimizing estradiol level for gonadotrophin-releasing hormone antagonist initiation among patients with simple tubal factor infertility
por: Wang, Yizhuo, et al.
Publicado: (2022)

Using automated imaging to interrogate gonadotrophin-releasing hormone receptor trafficking and function
por: Armstrong, S.P., et al.
Publicado: (2011)

Plasmid DNA vaccine coding eight repeats of gonadotrophin-releasing hormone induced atrophy of prostate in male mice
por: Rima, Umme K., et al.
Publicado: (2018)

Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia
por: Ansari, Mohammad Abdul Jalil, et al.
Publicado: (2008)

The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
por: Chen, Li, et al.
Publicado: (2023)

The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization
por: Lee, Kyung-Hee, et al.
Publicado: (2014)

Temporal and Spatial Regulation of CRE Recombinase Expression in Gonadotrophin-Releasing Hormone Neurones in the Mouse
por: Wolfe, A, et al.
Publicado: (2008)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Chung, Seung Ah, et al.
Publicado: (2021)

Review of Implant Gonadotrophin-Releasing Hormone Agonist Use: Experience in a Single Academic Center
por: Ni, Jennifer, et al.
Publicado: (2023)

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.
por: Jungwirth, A., et al.
Publicado: (1997)

The role of gonadotropin‐releasing hormone neurons in polycystic ovary syndrome
por: McCartney, Christopher R., et al.
Publicado: (2022)

Highlights of neuroanatomical discoveries of the mammalian gonadotropin‐releasing hormone system
por: Campbell, Rebecca E., et al.
Publicado: (2022)

Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts
por: Jacobs, E, et al.
Publicado: (1999)

Research Note: Polymorphisms of gonadotrophin-releasing hormone gene and their association with growth traits in quail (Coturnix Coturnix)
por: Wang, Xinle, et al.
Publicado: (2022)

The Effect of Lupinus albus on Growth Performance, Body Composition and Satiety Hormones of Male Pigs Immunized against Gonadotrophin Releasing Factor
por: Moore, Karen, et al.
Publicado: (2017)

Hormone naïve prostate cancer: predicting and maximizing response intervals
por: Moul, Judd W
Publicado: (2015)

The correlation of anandamide with gonadotrophin and sex steroid hormones during the menstrual cycle
por: Cui, Na, et al.
Publicado: (2017)

Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women
por: Bahaeldein, E, et al.
Publicado: (2018)

Interplay between nitric oxide and gonadotrophin-releasing hormone in the neuromodulation of the corpus luteum during late pregnancy in the rat
por: Vallcaneras, Sandra, et al.
Publicado: (2022)

A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
por: Asakawa, Jumpei, et al.
Publicado: (2018)

Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting
por: Kumar, Raj
Publicado: (2016)

Gonadotrophin-Releasing Hormone (GnRH) Analogues in the Treatment of Mixed Mullerian Tumours of the Uterus: Two Case Reports and Review
por: Katesmark, Michael, et al.
Publicado: (1998)

Human Chorionic Gonadotrophin: New Pleiotropic Functions for an “Old” Hormone During Pregnancy
por: Gridelet, Virginie, et al.
Publicado: (2020)

RF33 | PSUN04 Luteinizing Hormone-Chorionic Gonadotrophin Receptor in Pheochromocytomas
por: Lopez, Antoine-Guy, et al.
Publicado: (2022)

Apoptotic Death of Prostate Cancer Cells by a Gonadotropin-Releasing Hormone-II Antagonist
por: Park, Sumi, et al.
Publicado: (2014)

Progress in Clinical Research on Gonadotropin-Releasing Hormone Receptor Antagonists for the Treatment of Prostate Cancer
por: Liu, Yi-Fu, et al.
Publicado: (2021)

Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids
por: Kim, Eun Hee, et al.
Publicado: (2014)

Orthotopic Transplantation of Cryopreserved Mouse Ovaries and Gonadotrophin Releasing Hormone Analogues in the Restoration of Function following Chemotherapy-Induced Ovarian Damage
por: Li, Qing, et al.
Publicado: (2015)

Evaluation of adenomyosis after gonadotrophin-releasing hormone agonist therapy using ultrasound post-processing imaging: a pilot study
por: Chou, Szu-Yuan, et al.
Publicado: (2020)

Association between duration of gonadotrophin‐releasing hormone agonist use and cardiovascular risks: A population‐based competing‐risk analysis
por: Chan, Jeffrey S. K., et al.
Publicado: (2022)

Are thyrotropin‐releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid‐induced respiratory depression?
por: Algera, Marieke Hyke, et al.
Publicado: (2022)

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer
por: Sugino, Fumiya, et al.
Publicado: (2023)

SAT-603 Growth Hormone-Releasing Hormone (GHRH) Antagonists Stimulate Feeding in Mice
por: Leone, Sheila, et al.
Publicado: (2020)

COVID-19 and hormonal contraception
por: Cagnacci, Angelo, et al.
Publicado: (2022)

Use of early chemotherapy for hormone-sensitive prostate cancer: time for CHAARTED
por: Aragon-Ching, Jeanny B
Publicado: (2016)

Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer
por: Kawahara, Takashi
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_shd21ghr9rsddvep4ivnsr2of9